Ectopic pregnancy (EP) is estimated to be responsible for approximately 20% of all
pregnancy-related mortality and 46% early pregnancy mortality.1 Hemodynamically stable women
with EP are frequently managed with methotrexate (MTX) while multiple protocols like fixed
multiple doses, single-dose as well as two-dose regimens have been in practice for treating
EP, but no consensus exists regarding the optimum dosage regimen.